Markers of inflammation in sepsis

被引:62
作者
Takala, A
Nupponen, I
Kylänpää-Bäck, ML
Repo, H
机构
[1] Univ Helsinki, Cent Hosp, Dept Anesthesia & Intens Care Med, FI-00029 Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Surg, FI-00029 Helsinki, Finland
[3] Univ Helsinki, Cent Hosp, Dept Med, FI-00029 Helsinki, Finland
[4] Univ Helsinki, Cent Hosp, Hosp Children & Adolescent, FI-00029 Helsinki, Finland
[5] Univ Helsinki, Haartman Inst, Dept Bacteriol & Immunol, Helsinki, Finland
关键词
acute pancreatitis; CD11b; cytokine; innate immunity; organ dysfunction; sepsis; systemic inflammation;
D O I
10.1080/078538902321117841
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pathophysiology of sepsis is characterised by a whole body inflammatory reaction and concurrent activation of the host's anti-inflammatory mechanisms. The balance between pro- and anti-inflammatory reactions is critical for the outcome of the patient. Strongly activated phagocytes and high levels of proinflammatory cytokines occur in patients who are at risk of developing circulatory shock and multiple organ dysfunction. Extensive anti-inflammatory reaction, which is characterised by the presence of high levels of circulating anti-inflammatory cytokines and impaired innate and adaptive immune functions, renders critically ill patients prone to secondary infections. Evaluation of the immune-inflammatory status on admission to the hospital may be helpful in the early identification of patients who are bound to develop organ dysfunction. Such patients could possibly benefit from a mode of therapy aimed at modifying the course of inflammatory response. The use of inflammatory markers may also improve diagnosis of severe infection. The present review summarises the studies on markers of inflammation and immune suppression used, first, as predictors of organ dysfunction in patients with systemic inflammation, and, second, as indicators of infection in adults and neonates.
引用
收藏
页码:614 / 623
页数:10
相关论文
共 74 条
[1]   HIGH SERUM PROCALCITONIN CONCENTRATIONS IN PATIENTS WITH SEPSIS AND INFECTION [J].
ASSICOT, M ;
GENDREL, D ;
CARSIN, H ;
RAYMOND, J ;
GUILBAUD, J ;
BOHUON, C .
LANCET, 1993, 341 (8844) :515-518
[2]   Plasma levels and gene expression of granulocyte colony-stimulating factor, tumor necrosis factor-α, interleukin (IL)-1β, IL-6, IL-8, and soluble intercellular adhesion molecule-1 in neonatal early onset sepsis [J].
Berner, R ;
Niemeyer, CM ;
Leititis, JU ;
Funke, A ;
Schwab, C ;
Rau, U ;
Richter, K ;
Tawfeek, MSK ;
Clad, A ;
Brandis, M .
PEDIATRIC RESEARCH, 1998, 44 (04) :469-477
[3]   DEFINITIONS FOR SEPSIS AND ORGAN FAILURE AND GUIDELINES FOR THE USE OF INNOVATIVE THERAPIES IN SEPSIS [J].
BONE, RC ;
BALK, RA ;
CERRA, FB ;
DELLINGER, RP ;
FEIN, AM ;
KNAUS, WA ;
SCHEIN, RMH ;
SIBBALD, WJ .
CHEST, 1992, 101 (06) :1644-1655
[5]  
BOTHA AJ, 1995, J TRAUMA, V39, P411
[6]   Pro- and anti-inflammatory cytokines during acute severe pancreatitis: An early and sustained response, although unpredictable of death [J].
Brivet, FG ;
Emilie, D ;
Galanaud, P .
CRITICAL CARE MEDICINE, 1999, 27 (04) :749-755
[7]   RECOMBINANT HUMAN INTERLEUKIN-6 (IL-6/BSF-2/HSF) REGULATES THE SYNTHESIS OF ACUTE PHASE PROTEINS IN HUMAN HEPATOCYTES [J].
CASTELL, JV ;
GOMEZLECHON, MJ ;
DAVID, M ;
HIRANO, T ;
KISHIMOTO, T ;
HEINRICH, PC .
FEBS LETTERS, 1988, 232 (02) :347-350
[8]   Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon:: a review [J].
Cavaillon, JM ;
Adib-Conquy, M ;
Cloëz-Tayarani, I ;
Fitting, C .
JOURNAL OF ENDOTOXIN RESEARCH, 2001, 7 (02) :85-93
[9]   Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever [J].
Chirouze, C ;
Schuhmacher, H ;
Rabaud, C ;
Gil, H ;
Khayat, N ;
Estavoyer, JM ;
May, T ;
Hoen, B .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (02) :156-161
[10]  
COOMBES RC, 1974, LANCET, V1, P1080